Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
22nd Century Group reported third quarter 2026 revenue of $4.8 million, a 66% sequential increase, and achieved positive gross profit of $0.4 million. The company highlighted significant retail expansion for its Pinnacle VLN and Pinnacle Pure cigarette products, including a new distribution partnership with Gopuff. Management also noted a simplified capital structure following the redemption of Series B preferred stock and the elimination of outstanding warrants.
Term
Q3 2026
“The third quarter marked a period of accelerating commercial execution featuring expanded market adoption of our Pinnacle branded products. We grew revenue 66% sequentially to $4.8 million, turned gross profit positive, and meaningfully reduced our operating loss, all while continuing to expand retail distribution, increase consumer awareness and strengthen the commercial foundation for our VLN® products.”
Larry Firestone, Chief Executive Officer of 22nd Century Group
“Alongside this commercial progress, we significantly cleaned up our capital structure. Following quarter-end, we raised $5.8 million of net cash proceeds through an at-the-market offering, used $1.2 million of those proceeds to redeem an equal amount of our Series B convertible preferred stock at par, and enter the fourth quarter with no warrants outstanding.”
Larry Firestone, Chief Executive Officer of 22nd Century Group
Rezolute, Inc. entered into an underwriting agreement for a public offering of 22,040,976 shares of common stock and 3,800,000 pre-funded warrants, expected to raise gross proceeds of approximately $100 million. The financing was led by Frazier Life Sciences and is intended to fund commercialization preparation for ersodetug and general corporate purposes.
Biohaven Ltd. is delivering an investor presentation at the Jefferies Global Healthcare Conference in London from November 16-19, 2026. The presentation provides a corporate update on the company's clinical pipeline, including programs in glutamate modulation, immunology, and oncology.
Silexion Therapeutics reported Q3 2026 financial results, highlighting the dosing of the first patient in its Phase 2/3 clinical trial of SIL204 for pancreatic cancer. The company strengthened its balance sheet through a public offering and warrant inducement, ending the quarter with $4.8 million in cash and $3.0 million in shareholders' equity.
Term
Q3 2026
“In the third quarter, we began treating patients with SIL204 in our Phase 2/3 trial in pancreatic cancer. After opening our first clinical site at Tel Aviv Sourasky Medical Center in July, we dosed the first patient at the end of September. At the same time, our laboratory work continued to strengthen the case for SIL204, with new data suggesting it may help the immune system recognize cancer cells, and showing that it uses natural carriers in the blood to enter cancer cells. Our focus now is on enrolling the first group of patients and bringing more hospitals in Israel and Germany into the trial.”
Ilan Hadar, Chairman and Chief Executive Officer
“During the third quarter, we completed a public offering and a warrant inducement transaction and continued sales under our at-the-market facility, increasing our cash and cash equivalents to $4.8 million and shareholders’ equity to approximately $3.0 million as of September 30, 2026. This financial progress strengthens our balance sheet and supports the continued advancement of SIL204 as we enroll patients in the Phase 2/3 trial.”
KALA BIO received a determination from the Nasdaq Hearings Panel granting its request to continue its listing on The Nasdaq Capital Market subject to specific conditions. The company must evidence a closing bid price of at least $1.00 per share for ten consecutive business days by November 30, 2026, and maintain that price through February 23, 2027. Failure to meet these conditions or any other listing rules during this period may result in delisting.
DataMEDS AI, Inc. entered into an at-the-market (ATM) sales agreement with Dawson James Securities, Inc. to establish an offering program for its common stock. The company may sell shares from time to time at prevailing market prices, though it is not obligated to make any sales. The Sales Agent will receive a fixed commission of 3.0% of the gross proceeds from any shares sold.
T. Rowe Price OHA Select Private Credit Fund Dividend
T. Rowe Price OHA Select Private Credit Fund declared total distributions of $0.60 per share for the third quarter of 2026, representing an annualized distribution rate of 9.2%. The fund reported net investment income of $0.60 per share and a net asset value (NAV) of $26.02 per share as of September 30, 2026.
For the nine months ended September 30, 2026, OHA Senior Private Lending Fund reported a significant decrease in net increase in net assets resulting from operations to $0.29 million, down from $73.96 million in the prior year period, primarily driven by a $26.02 million net unrealized depreciation. Total investment income also saw a decline to $31.00 million compared to $34.62 million in 2025.
Origin Tea Inc. reported $0 revenue for fiscal 2026 as it transitioned from no operations to establishing tea procurement and distribution infrastructure. The company reported a net loss of $54,140 and a working capital deficit of $100,287, leading to a going concern qualification from its auditors.
For the nine months ended September 30, 2026, the Fund reported total investment income of $230.5 million and net investment income of $111.6 million. Total net assets stood at $1.63 billion with a net asset value per share of $26.02 across all classes, reflecting a decrease from $26.89 at the end of 2025.
ESG Inc. completed a split-off of its China operations on May 26, 2026, resulting in a significant reduction in total assets from $26.9 million to $145,551. The company reported a net loss of $1.1 million for the nine months ended September 30, 2026, and management has expressed substantial doubt about its ability to continue as a going concern due to limited revenue and a working capital deficit.
Research Alliance Corp III is a blank check company that entered into a Business Combination Agreement with OHBP on July 26, 2026, with an expected closing in Q4 2026. The company reported a backstop liability of $1,687,399 as of September 30, 2026, and recently secured a $3,000,000 working capital loan from its Sponsor to fund transaction expenses.
Sky Quarry Inc. reported a significant decrease in net sales to $30,528 for the nine months ended September 30, 2026, compared to $12.2 million in the prior year, resulting in a net loss of $10.3 million. Despite the operational loss, the company significantly strengthened its cash position to $3.76 million through common stock subscriptions totaling over $13.9 million.
Hawaiian Electric Industries Investor Presentation
Hawaiian Electric Industries (HEI) filed a formal investor presentation for meetings beginning November 16, 2026, detailing its strategic recovery following the 2023 Maui wildfires. The presentation highlights significant de-risking milestones, including a court-approved global settlement, rebuilt liquidity of approximately $1.3 billion, and the transition to a pure-play utility model.
Callan JMB Inc. reported a net loss of $7.18 million for the nine months ended September 30, 2026, compared to a $5.37 million loss in the prior year period, driven by a 20% decline in revenue and significant ELOC facility transaction expenses. The company's cash position decreased to $1.78 million as it continues to rely on equity line of credit (ELOC) financing and a $1.0 million line of credit to fund operations.
TOMI Environmental Solutions reported preliminary Q3 2026 results, highlighting a 24% year-over-year revenue increase to $2.49 million and a return to positive operating income of $30,000. The company noted that full GAAP results, including net loss and EPS, are pending a final accounting review of the conversion of $2.5 million in convertible notes during the quarter.
American Picture House Corp reported a net loss of $349,421 for the nine months ended September 30, 2026, a significant improvement from the $1,355,022 loss in the prior year period. The company remains in a deficit position with a total stockholders' deficit of $476,364 and reported minimal revenue of $1,220 for the year-to-date period.
CorMedix Inc. announced a definitive agreement to acquire substantially all of the assets of Heron Therapeutics, Inc., including both commercial and pipeline assets. The acquisition is intended to provide scale and diversification to CorMedix's institutional care growth strategy and remains subject to Heron stockholder approval and regulatory clearance.
For the three months ended September 30, 2026, APPlife Digital Solutions reported a net loss of $1,129,902 on revenue of $195,575, a significant decline from the $96,322 net income reported in the prior year period. The loss was driven by a substantial increase in other expenses, specifically a $422,958 change in the fair value of derivative liabilities and $256,169 in debt discount amortization.
NEXGEL, INC. reported a net loss of $5.68 million for the nine months ended September 30, 2026, compared to $2.03 million in the prior year, driven by significant increases in selling, general, and administrative expenses. Total assets grew to $23.90 million following a major $12.34 million increase in intangible assets, while the company underwent a 1-for-20 reverse stock split in October 2026.
For the nine months ended September 30, 2026, Apollo Infrastructure Co LLC reported total investment income of $56.1 million, driven by $41.7 million in interest income and $14.3 million in dividends. Total net assets grew to $2.196 billion as of September 30, 2026, compared to $1.736 billion at the end of 2025, supported by significant investment activity and the utilization of a $380 million credit facility.
For the nine months ended September 30, 2026, KKR Enhanced US Direct Lending Fund-L Inc. reported total investment income of $95.8 million and net investment income of $62.1 million. Net assets grew to $857.5 million, driven by $169.5 million in subscriptions, though net asset value per share decreased from $1,031.53 to $1,002.25 during the period.
Ministry Partners Investment Company, LLC reported a net loss of $843 thousand for the nine months ended September 30, 2026, compared to a net income of $195 thousand in the prior year period. The decline was driven by lower interest income on loans and a significant increase in salaries and benefits expenses.
Armlogi Holding Corp. reported a net loss of $4.1 million for the quarter ended September 30, 2026, an improvement from the $6.5 million loss in the prior year period. Revenue decreased to $36.9 million from $49.5 million, though the company achieved a positive gross profit of $0.9 million compared to a gross loss in 2025.
Scienture Holdings, Inc. reported a net loss of $12.2 million for the nine months ended September 30, 2026, compared to a $13.4 million loss in the prior year. While revenues increased significantly to $1.65 million, the company remains focused on R&D and specialty pharmaceutical development following its acquisition of Scienture, LLC and the disposition of legacy subsidiaries.
Greenland Energy Company has reached a definitive agreement to acquire the entire issued share capital of 80 Mile plc (AIM: 80M) in an all-share transaction. Under the terms, 80 Mile shareholders will receive 0.0079485 shares of Greenland common stock for each share held, implying a deal value of approximately £74 million. The acquisition will be implemented via a court-sanctioned scheme of arrangement and includes the appointment of one 80 Mile director to the Greenland board.
Creative Media & Community Trust Financial Results
Creative Media & Community Trust Corp (CMCT) reported its Q3 2026 financial results, highlighting a net loss of $19.1 million and a 54.5% increase in segment net operating income to $10.8 million. The company noted significant progress in improving its balance sheet and is currently marketing several real estate assets for sale while seeing improved occupancy in its multifamily portfolio.
Farmers & Merchants Bancorp declared a quarterly cash dividend of $5.85 per share, representing a 4.5% increase from the previous quarter. The dividend is payable on January 4, 2027, to shareholders of record as of December 4, 2026, marking the company's 61st consecutive year of dividend increases.
Foxx Development Holdings Inc. reported a net loss of $4.18 million for the quarter ended September 30, 2026, compared to a $2.87 million loss in the prior year period, driven by lower revenues and higher interest expenses. Total revenues decreased to $17.93 million from $20.22 million, while the company's stockholders' deficit widened to $60.77 million.
BeyondSpring Inc. reported a significant net income of $50.5 million for the quarter ended September 30, 2026, primarily driven by a $53.7 million gain on the sale of subsidiary interests and the deconsolidation of discontinued operations. Despite this one-time gain, the company continues to experience operating losses from continuing operations, totaling $2.1 million for the quarter, as it remains in the development stage with no revenue.